Literature DB >> 790088

Insulin, glucagon, and the control of hepatic structure, function, and capacity for regeneration.

T E Starzl, K A Porter, C W Putnam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 790088      PMCID： PMC3032572          DOI： 10.1016/s0026-0495(76)80158-8

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  14 in total

1.  IMMUNOSUPPRESSION AFTER EXPERIMENTAL AND CLINICAL HOMOTRANSPLANTATION OF THE LIVER.

Authors:  T E STARZL; T L MARCHIORO; D T ROWLANDS; C H KIRKPATRICK; W E WILSON; D RIFKIND; W R WADDELL
Journal:  Ann Surg       Date:  1964-09       Impact factor: 12.969

2.  PHYSIOLOGIC REQUIREMENTS FOR AUXILIARY LIVER HOMOTRANSPLANTATION.

Authors:  T L MARCHIORO; K A PORTER; T C DICKINSON; T D FARIS; T E STARZI
Journal:  Surg Gynecol Obstet       Date:  1965-07

3.  Portacaval shunt in hyperlipoproteinaemia.

Authors:  T E Starzl; C W Putnam; H P Chase; K A Porter
Journal:  Lancet       Date:  1973-10-27       Impact factor: 79.321

4.  The effect of partial portacaval transposition on the canine liver.

Authors:  T L Marchioro; K A Porter; B I Brown; J B Otte; T E Starzl
Journal:  Surgery       Date:  1967-05       Impact factor: 3.982

5.  Portal diversion for the treatment of glycogen storage disease in humans.

Authors:  T E Starzl; C W Putnam; K A Porter; C G Halgrimson; J Corman; B I Brown; R W Gotlin; D O Rodgerson; H L Greene
Journal:  Ann Surg       Date:  1973-10       Impact factor: 12.969

6.  The specific influence of nonhepatic splanchnic venous blood flow on the liver.

Authors:  T L Marchioro; K A Porter; B I Brown; T D Faris; T J Herrmann; A Sudweeks; T E Starzl
Journal:  Surg Forum       Date:  1965

7.  Hepatic encephalopathy and light and electron micrographic changes of the baboon liver after portal diversion.

Authors:  C W Putnam; K A Porter; T E Starzl
Journal:  Ann Surg       Date:  1976-08       Impact factor: 12.969

8.  The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs.

Authors:  T E Starzl; K A Porter; N Kashiwagi; I Y Lee; W J Russsell; C W Putnam
Journal:  Surg Gynecol Obstet       Date:  1975-04

9.  The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons.

Authors:  T E Starzl; I Y Lee; K A Porter; C W Putnam
Journal:  Surg Gynecol Obstet       Date:  1975-03

10.  Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration.

Authors:  T E Starzl; K A Porter; N Kashiwagi
Journal:  Surg Gynecol Obstet       Date:  1975-12
View more
  5 in total

Review 1.  Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas.

Authors:  George K Michalopoulos
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

2.  Effect of partial portal vein ligation on hepatic regeneration.

Authors:  D Kahn; M Kajani; Q Zeng; H S Lai; P K Eagon; L Makowka; T E Starzl; D H Van Thiel
Journal:  J Invest Surg       Date:  1988       Impact factor: 2.533

3.  Growth of liver allografts over time in pediatric transplant recipients.

Authors:  S G Chaudhry; S Bentley-Hibbert; J Stern; S Lobritto; M Martinez; J Vittorio; K J Halazun; H T Lee; J Emond; T Kato; B Samstein; A Griesemer
Journal:  Pediatr Transplant       Date:  2018-01-15

4.  Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axis.

Authors:  Lianne de Haan; Sarah J van der Lely; Anne-Loes K Warps; Quincy Hofsink; Pim B Olthof; Mark J de Keijzer; Daniël A Lionarons; Lionel Mendes-Dias; Bote G Bruinsma; Korkut Uygun; Hartmut Jaeschke; Geoffrey C Farrell; Narci Teoh; Rowan F van Golen; Tiangang Li; Michal Heger
Journal:  J Clin Transl Res       Date:  2018-02-16

5.  Nrf2 is involved in maintaining hepatocyte identity during liver regeneration.

Authors:  Yuhong Zou; Joonyong Lee; Shashank Manohar Nambiar; Min Hu; Wenjuan Rui; Qi Bao; Jefferson Y Chan; Guoli Dai
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.